Medicine guide
Adbry
300 mg/2mL · Injection, Solution
- Prescription only
- Interleukin-13 Antagonist
- Active substance
- Tralokinumab-Ldrm
- Made by
- LEO Pharma Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicines
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | LEO Pharma Inc. |
|---|---|
| Active substance | Tralokinumab-Ldrm |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 300 mg/2mL |
| Form | Injection, Solution |
| Route | Subcutaneous |
| Packs | 1 SYRINGE, GLASS in 1 CARTON / 2 mL in 1 SYRINGE, GLASS · 2 SYRINGE, GLASS in 1 CARTON / 2 mL in 1 SYRINGE, GLASS |
| NDC | 50222-350 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Solution2 products
- 150 mg/mL
- 300 mg/2mL
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.